Abstract
AbstractIn this clinical study, the cerebrospinal fluid (CSF) level of a Novemberel form of the β‐amyloid peptide (Aβ) extending to position 42 (Aβ42) was determined in patients with Alzheimer's disease (AD) as well as controls. In addition to measurement of CSF Aβ42 levels, total Aβ peptides, microtubule‐associated protein τ, and apolipoprotein E (ApoE) genotype were also assessed. It is interesting that CSF Aβ42 levels were found to be significantly lower in AD patients relative to controls, whereas total Aβ levels were not. Aβ42 has recently been shown to preferentially deposit in the brain tissue of patients with AD, suggesting that diminished clearance may account for its reduction in CSF. As previously reported, τ levels were increased in AD patients; however, neither Aβ42 nor τ levels were apparently influenced by the ApoE genotype.
Bibliography
Motter, R., VigoâPelfrey, C., Kholodenko, D., Barbour, R., JohnsonâWood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., Olson, D., Southwick, P., Wolfert, R., Munroe, B., Lieberburg, I., Seubert, P., & Schenk, D. (1995). Reduction of βâamyloid peptide42 in the cerebrospinal fluid of patients with Alzheimerâs disease. Annals of Neurology, 38(4), 643â648. Portico.
Authors
17
- R. Motter (first)
- C. Vigo‐Pelfrey (additional)
- D. Kholodenko (additional)
- R. Barbour (additional)
- K. Johnson‐Wood (additional)
- D. Galasko (additional)
- L. Chang (additional)
- B. Miller (additional)
- C. Clark (additional)
- R. Green (additional)
- D. Olson (additional)
- P. Southwick (additional)
- R. Wolfert (additional)
- B. Munroe (additional)
- I. Lieberburg (additional)
- P. Seubert (additional)
- D. Schenk (additional)
References
25
Referenced
528
{'key': 'e_1_2_1_2_2', 'volume-title': 'Dementia: a clinical approach', 'author': 'Cummings JL', 'year': '1992'}
/ Dementia: a clinical approach by Cummings JL (1992)10.1001/archneur.1985.04060100083029
10.1212/WNL.43.8.1467
10.1111/j.1471-4159.1993.tb09823.x
10.1212/WNL.45.4.788
10.1002/ana.410360616
10.1016/0896-6273(94)90458-8
10.1016/S0021-9258(18)53661-9
10.1111/j.1471-4159.1993.tb09841.x
10.1016/0022-3956(75)90026-6
10.1111/j.2044-8260.1967.tb00530.x
10.1001/archneur.1975.00490510088009
10.1001/archneur.1994.00540210060013
{'key': 'e_1_2_1_15_2', 'first-page': '939', 'article-title': 'Clinical diagnosis of AD', 'volume': '34', 'author': 'McKann G', 'year': '1984', 'journal-title': 'Neurology'}
/ Neurology / Clinical diagnosis of AD by McKann G (1984)10.1136/jnnp.57.4.416
10.1016/B978-0-12-372180-8.50022-6
10.1016/0140-6736(91)92823-K
10.1038/359325a0
10.1111/j.1471-4159.1992.tb09432.x
10.1056/NEJM198412133112406
{'key': 'e_1_2_1_22_2', 'first-page': '201', 'article-title': "The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4", 'volume': '1', 'author': 'Mann DMA', 'year': '1992', 'journal-title': 'Neurodegeneration'}
/ Neurodegeneration / The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4 by Mann DMA (1992)10.1016/0197-4580(91)90006-6
10.1073/pnas.90.5.1977
10.1006/exnr.1994.1019
{'key': 'e_1_2_1_26_2', 'first-page': '86', 'article-title': "Alzheimer's disease. A double labeling immunohistochemical study of senile plaques", 'volume': '132', 'author': 'Dickson DW', 'year': '1988', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Alzheimer's disease. A double labeling immunohistochemical study of senile plaques by Dickson DW (1988)
Dates
Type | When |
---|---|
Created | 20 years, 8 months ago (Jan. 1, 2005, 11:27 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 26, 2023, 2:06 p.m.) |
Indexed | 1 day, 8 hours ago (Sept. 2, 2025, 6:37 a.m.) |
Issued | 29 years, 11 months ago (Oct. 1, 1995) |
Published | 29 years, 11 months ago (Oct. 1, 1995) |
Published Online | 20 years, 10 months ago (Oct. 8, 2004) |
Published Print | 29 years, 11 months ago (Oct. 1, 1995) |
@article{Motter_1995, title={Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease}, volume={38}, ISSN={1531-8249}, url={http://dx.doi.org/10.1002/ana.410380413}, DOI={10.1002/ana.410380413}, number={4}, journal={Annals of Neurology}, publisher={Wiley}, author={Motter, R. and Vigo‐Pelfrey, C. and Kholodenko, D. and Barbour, R. and Johnson‐Wood, K. and Galasko, D. and Chang, L. and Miller, B. and Clark, C. and Green, R. and Olson, D. and Southwick, P. and Wolfert, R. and Munroe, B. and Lieberburg, I. and Seubert, P. and Schenk, D.}, year={1995}, month=oct, pages={643–648} }